| 000 | 01732 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515011945.0 | ||
| 264 | 0 | _c20060622 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1196/annals.1339.042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrooks, Alan D | |
| 245 | 0 | 0 |
_aThe proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cNov 2005 |
||
| 300 |
_a160-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
| 650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
| 650 | 0 | 4 |
_aNeoplasms _xmetabolism |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 |
_aPyrazines _xpharmacology |
| 650 | 0 | 4 | _aTNF-Related Apoptosis-Inducing Ligand |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
| 700 | 1 | _aRamirez, Teresa | |
| 700 | 1 | _aToh, Uhi | |
| 700 | 1 | _aOnksen, Jennifer | |
| 700 | 1 | _aElliott, Peter J | |
| 700 | 1 | _aMurphy, William J | |
| 700 | 1 | _aSayers, Thomas J | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 1059 _gp. 160-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1196/annals.1339.042 _zAvailable from publisher's website |
| 999 |
_c16000378 _d16000378 |
||